company background image
MLAB logo

Mesa Laboratories NasdaqGS:MLAB Stock Report

Last Price

US$107.25

Market Cap

US$578.5m

7D

2.7%

1Y

-36.6%

Updated

27 Mar, 2024

Data

Company Financials +

Mesa Laboratories, Inc.

NasdaqGS:MLAB Stock Report

Market Cap: US$578.5m

MLAB Stock Overview

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

MLAB fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance1/6
Financial Health1/6
Dividends0/6

Mesa Laboratories, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mesa Laboratories
Historical stock prices
Current Share PriceUS$107.25
52 Week HighUS$187.75
52 Week LowUS$82.86
Beta0.83
1 Month Change1.15%
3 Month Change1.18%
1 Year Change-36.62%
3 Year Change-55.95%
5 Year Change-53.99%
Change since IPO3,402.04%

Recent News & Updates

Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mar 15
Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08
Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mar 15
Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08
Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Dec 05
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Sep 28
Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Aug 09
Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Jun 28
We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

May 31
Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Apr 12
A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Mar 13
Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Dec 20
Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Mesa Laboratories declares $0.16 dividend

Oct 03

Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced

Sep 09

Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?

Sep 06
Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?

Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Aug 08
Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Mesa Laboratories GAAP EPS of -$0.27 misses by $0.27, revenue of $50.45M misses by $1.72M

Aug 04

Mesa Laboratories declares $0.16 dividend

Jul 07

A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

May 06
A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Growth Investors: Industry Analysts Just Upgraded Their Mesa Laboratories, Inc. (NASDAQ:MLAB) Revenue Forecasts By 14%

Apr 09
Growth Investors: Industry Analysts Just Upgraded Their Mesa Laboratories, Inc. (NASDAQ:MLAB) Revenue Forecasts By 14%

We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Dec 08
We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Shareholder Returns

MLABUS Life SciencesUS Market
7D2.7%-0.2%0.4%
1Y-36.6%4.5%28.8%

Return vs Industry: MLAB underperformed the US Life Sciences industry which returned 3.9% over the past year.

Return vs Market: MLAB underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is MLAB's price volatile compared to industry and market?
MLAB volatility
MLAB Average Weekly Movement6.9%
Life Sciences Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: MLAB has not had significant price volatility in the past 3 months.

Volatility Over Time: MLAB's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982698Gary Owenshttps://www.mesalabs.com

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications.

Mesa Laboratories, Inc. Fundamentals Summary

How do Mesa Laboratories's earnings and revenue compare to its market cap?
MLAB fundamental statistics
Market capUS$578.51m
Earnings (TTM)US$948.00k
Revenue (TTM)US$212.87m

610.2x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MLAB income statement (TTM)
RevenueUS$212.87m
Cost of RevenueUS$82.57m
Gross ProfitUS$130.31m
Other ExpensesUS$129.36m
EarningsUS$948.00k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.18
Gross Margin61.21%
Net Profit Margin0.45%
Debt/Equity Ratio57.8%

How did MLAB perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

363%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.